HLNCF broke above its upper Bollinger Band on November 27, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 15 similar instances where the stock broke above the upper band. In of the 15 cases the stock fell afterwards. This puts the odds of success at .
The Momentum Indicator moved below the 0 level on December 17, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on HLNCF as a result. In of 66 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HLNCF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where HLNCF's RSI Oscillator exited the oversold zone, of 6 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 25 cases where HLNCF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for HLNCF just turned positive on November 19, 2024. Looking at past instances where HLNCF's MACD turned positive, the stock continued to rise in of 26 cases over the following month. The odds of a continued upward trend are .
HLNCF moved above its 50-day moving average on December 16, 2024 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HLNCF advanced for three days, in of 60 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 89 cases where HLNCF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.846) is normal, around the industry mean (57.958). P/E Ratio (27.248) is within average values for comparable stocks, (89.727). HLNCF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.947). Dividend Yield (0.007) settles around the average of (0.122) among similar stocks. P/S Ratio (2.687) is also within normal values, averaging (19.472).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HLNCF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HLNCF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
Industry PharmaceuticalsOther
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
CANC | 25.56 | 0.17 | +0.69% |
Tema Oncology ETF | |||
IGLB | 50.88 | 0.02 | +0.04% |
iShares 10+ Year Invmt Grd Corp Bd ETF | |||
CSM | 68.07 | -0.25 | -0.37% |
ProShares Large Cap Core Plus | |||
HSCZ | 32.38 | -0.15 | -0.45% |
iShares Currency Hdgd MSCI EAFE SmCp ETF | |||
WEIX | 27.26 | -0.33 | -1.20% |
Dynamic Short Short-Term Volatil Fut ETF |
A.I.dvisor indicates that over the last year, HLNCF has been loosely correlated with HLN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HLNCF jumps, then HLN could also see price increases.
Ticker / NAME | Correlation To HLNCF | 1D Price Change % | ||
---|---|---|---|---|
HLNCF | 100% | N/A | ||
HLN - HLNCF | 49% Loosely correlated | +1.95% | ||
SGIOF - HLNCF | 21% Poorly correlated | N/A | ||
STEK - HLNCF | 11% Poorly correlated | -1.80% | ||
EAPIF - HLNCF | 11% Poorly correlated | -10.63% | ||
ZTS - HLNCF | 10% Poorly correlated | -2.86% | ||
More |
Ticker / NAME | Correlation To HLNCF | 1D Price Change % |
---|---|---|
HLNCF | 100% | N/A |
Pharmaceuticals category (308 stocks) | 10% Poorly correlated | -1.42% |
Pharmaceuticals: Other category (226 stocks) | 7% Poorly correlated | -1.49% |